August 2016 in “Journal of Investigative Dermatology” EZH2 is essential for hair growth and skin cell development.
1 citations
,
May 2006 in “Hair transplant forum international” Well-designed clinical trials are needed to improve hair restoration methods.
April 2024 in “International Journal of Sexually Transmitted Diseases” Syphilis cases and re-infections increased, highlighting the need for ongoing prevention and treatment.
Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.
June 2008 in “Experimental Dermatology” 17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.
May 2021 in “Journal of the Endocrine Society” A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.
November 2024 in “Journal of Clinical Medicine” The treatment improved hair thickness, shine, and reduced hair loss effectively.
July 2025 in “Journal of Investigative Dermatology”
September 2003 in “Hair transplant forum international” The document's content could not be understood or processed.
December 2023 in “Journal of the American Academy of Dermatology” Refugee patients face long wait times for dermatology care, worsening health disparities.
July 2025 in “Journal of Investigative Dermatology” Collagen scaffolds in cell therapy can transform skin to be more resilient and pressure-responsive.
A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.
115 citations
,
January 2001 in “American journal of clinical dermatology” Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.
May 2017 in “Hair transplant forum international” The event was a significant and transformative experience in the field of hair transplantation.
1 citations
,
July 2021 in “DOAJ (DOAJ: Directory of Open Access Journals)”
April 2023 in “Dohuk medical journal” People with telogen effluvium often have much lower vitamin D levels than healthy individuals.
Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.
2 citations
,
March 2012 in “JAMA” Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.
2 citations
,
July 2021 in “Annales De Dermatologie Et De Venereologie” Vulvar acne, also known as "vulvar Fordyce adenitis", is a condition causing painful bumps on the labia, and it's not always effectively treated with common acne medications, but isotretinoin has shown promise.
March 2024 in “Journal of drugs in dermatology” HASHA is a safe and effective option for chin augmentation.
September 1998 in “Journal of the European Academy of Dermatology and Venereology”
2 citations
,
October 2015 in “The New England Journal of Medicine” The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.
8 citations
,
June 2022 in “Cancers” Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.
November 2025 in “Archives of Dermatological Research” Limelight (CB-EVs) safely promotes hair growth.
Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.
May 2024 in “Portuguese journal of dermatology and venereology” Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.
February 2026 in “Bioscientia Medicina Journal of Biomedicine and Translational Research” Eosinophilic pustular folliculitis should be considered in teens with persistent skin issues for accurate diagnosis and treatment.
May 1997 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
9 citations
,
November 1991 in “American Journal of Kidney Diseases” August 2023 in “Zenodo (CERN European Organization for Nuclear Research)”